Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
ANTI-CTLA4 IMMUNOMODULATION CAN SIGNIFICANTLY REDUCE LYMP... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
ANTI-CTLA4 IMMUNOMODULATION CAN SIGNIFICANTLY REDUCE LYMPHEDEMA DEVELOPMENT BY INCREASING TREG-MEDIATED IMMUNOSUPPRESSION
0
Authors
Stefan Wolf
7 more
Stefan Wolf
•
N Nuñez
5 more
•
Epameinondas Gousopoulos
Published
November 27, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of Plastic Reconstructive & Aesthetic Surgery
Topics
Medicine
Cancer Oncology
Immunology
Internal Medicine
Treg Cell
Show all topics
DOI
10.1016/j.bjps.2024.08.017
